May 10 (Reuters) - Cipher Pharmaceuticals Inc CPH.TO :
* CIPHER PHARMACEUTICALS REPORTS Q1 2018 RESULTS
* Q1 LOSS PER SHARE $0.04 FROM CONTINUING OPERATIONS
* Q1 REVENUE $4.6 MILLION VERSUS $8.1 MILLION
* EXPECTS TO ADD SIX NEW PRODUCTS FROM ITS EXISTING PIPELINE TO ITS CANADIAN COMMERCIAL PORTFOLIO IN 2018 AND 2019
* CONTINUES TO PURSUE NEW IN-LICENSING OPPORTUNITIES AND ACQUISITIONS TO FURTHER EXPAND ITS NEAR-TERM PRODUCT PIPELINE
* EXPECTS ITS GLOBAL LICENSING BUSINESS TO PROVIDE A "SOLID BASE" OF HIGH-MARGIN ROYALTY REVENUE IN 2018